Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic to Market, Sell Nanogen s NanoChip Platform in Parts of Europe

NEW YORK, Jan. 15 (GenomeWeb News) - Transgenomic will market and sell Nanogen's NanoChip molecular biology workstation in selected Western European countries, the companies said today.


The reason, according to both companies, is that the NanoChip platform "complements" the ability of Transgenomic's WAVE system to scan for unknown gene mutations, and that Transgenomic "has a large, well-established European customer base."


"This agreement is part of a strategy of providing total complementary solutions for the genetic research and clinical laboratory markets in Europe," said Collin D'Silva, Transgenomic's CEO.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.